Discover Clobazam (N03), a benzodiazepine used to treat epilepsy, particularly Lennox-Gastaut syndrome. Learn about its dosage, side effects, and benefits for seizure control.
Browse our catalog for available pharmaceutical products and competitive pricing.
Clobazam is a pharmaceutical compound classified as a 1,5-benzodiazepine, primarily recognized for its anticonvulsant and anxiolytic properties. Unlike most benzodiazepines which are 1,4-benzodiazepines, Clobazam's unique chemical structure contributes to its specific pharmacological profile, making it particularly effective in the management of certain seizure disorders. It acts as a central nervous system (CNS) depressant, reducing neuronal excitability and promoting a calming effect. Approved in many countries, it serves as an important medication in the therapeutic arsenal for epilepsy.
The history of Clobazam dates back to its synthesis in the 1960s. It was first introduced clinically in the early 1970s in Europe, gaining recognition for its efficacy in treating various forms of epilepsy, especially in cases resistant to other anticonvulsants. Its distinct structure and mechanism of action led to its eventual approval in the United States in 2011 specifically for the adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in adults and children aged 2 years and older. This approval underscored its value as a specialized antiepileptic drug (AED).
As a benzodiazepine, Clobazam belongs to a class of psychoactive drugs that are used to treat a range of conditions including anxiety, insomnia, and seizures. Its ATC (Anatomical Therapeutic Chemical) code is N03, which designates it as an antiepileptic drug. While it shares the general benzodiazepine mechanism of action, its clinical profile, characterized by a relatively slow onset and long duration of action, along with a somewhat lower propensity for sedation compared to some other benzodiazepines at equipotent anticonvulsant doses, makes it a valuable option in chronic seizure management. However, like all benzodiazepines, it carries risks of tolerance, dependence, and withdrawal if not managed carefully.
The primary mechanism of action for Clobazam, like other benzodiazepines, involves enhancing the effects of gamma-aminobutyric acid (GABA), the principal inhibitory neurotransmitter in the central nervous system. Clobazam selectively binds to a specific allosteric site on the GABA-A receptor complex, which is a ligand-gated ion channel. This binding event does not directly open the chloride channel but rather increases the frequency of chloride channel opening when GABA binds to its primary recognition site on the receptor. This potentiation of GABAergic neurotransmission leads to a cascade of inhibitory effects within the brain.
By increasing the influx of chloride ions into neurons, the binding of Clobazam to the GABA-A receptor results in hyperpolarization of the neuronal cell membrane. This hyperpolarization makes the neuron less excitable and more resistant to depolarization, thereby inhibiting the generation and propagation of action potentials. In the context of epilepsy, this reduction in neuronal excitability helps to stabilize overactive neural circuits, preventing the uncontrolled electrical discharges that characterize seizures. The unique 1,5-benzodiazepine structure of Clobazam may contribute to its distinct pharmacokinetic and pharmacodynamic properties, influencing its selectivity and efficacy in specific seizure types compared to 1,4-benzodiazepines.
Clobazam is primarily utilized as an antiepileptic drug, particularly in cases where other treatments have proven insufficient or for specific, difficult-to-treat seizure disorders. Its efficacy extends to various seizure types, often serving as an adjunctive therapy to complement other anticonvulsants. Its benzodiazepine properties also lend it to short-term use in other neurological and psychiatric contexts, although its long-term use outside of epilepsy is generally discouraged due to risks of dependence and tolerance.
The dosage of Clobazam must be carefully individualized based on the patient's age, weight, medical condition, and response to treatment. It is typically initiated at a low dose and gradually titrated upwards to achieve optimal therapeutic effect while minimizing side effects. Abrupt discontinuation should be avoided due to the risk of withdrawal seizures or other withdrawal symptoms. Always adhere strictly to the prescribing physician's instructions.
| Indication | Typical Dose | Frequency | Route |
|---|---|---|---|
| Lennox-Gastaut Syndrome (Adults) | 5 mg/day initially, titrated up to 20 mg twice daily | Once or twice daily | Oral |
| Lennox-Gastaut Syndrome (Children >2 years) | 0.1 mg/kg/day initially, titrated up to 1 mg/kg/day (not exceeding 40 mg/day) | Once or twice daily | Oral |
| Short-term Anxiety (Adults, off-label) | 10-20 mg/day | Once or twice daily | Oral |
| Elderly or Hepatically Impaired Patients | Lower initial doses (e.g., 5 mg/day) with slower titration | Once or twice daily | Oral |
Important: Always follow your prescriber instructions. Dosages vary by weight, age, and condition.
Like all medications, Clobazam can cause side effects. These can range from mild and transient to more serious and persistent. The incidence and severity of side effects are often dose-dependent and can vary significantly among individuals. It is crucial to report any adverse reactions to a healthcare professional.
Clobazam is metabolized primarily by the liver, particularly via the CYP2C19 enzyme, and its active metabolite, N-desmethylclobazam, is further metabolized by CYP3A4. Therefore, co-administration with other drugs that inhibit or induce these enzymes, or drugs that have additive CNS depressant effects, can significantly alter Clobazam's efficacy and safety profile. Always inform your doctor about all medications, supplements, and herbal products you are taking.
Medical Disclaimer: This information is for educational purposes only. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.
While Clobazam is used for chronic conditions like Lennox-Gastaut Syndrome, long-term use, particularly at higher doses, carries risks of tolerance, physical dependence, and withdrawal symptoms upon discontinuation. It should only be used long-term under strict medical supervision, with regular reassessment of its necessity and dosage, and careful monitoring for side effects and dependence. Abrupt cessation after prolonged use can lead to severe withdrawal, including seizures.
Yes, Clobazam can be taken with or without food. Taking it with food may help to reduce any potential gastrointestinal upset. However, for consistent absorption, it's generally advisable to take it consistently with respect to meals, or as directed by your healthcare provider.
If you miss a dose of Clobazam, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and resume your regular dosing schedule. Do not take a double dose to make up for a missed one, as this can increase the risk of side effects. Always consult your prescriber for specific advice on missed doses.
Clobazam is a prescription-only medication. It must be prescribed by a licensed healthcare professional and obtained from a legitimate, licensed pharmacy. It is illegal and unsafe to attempt to buy Clobazam without a valid prescription or from unregulated online sources, as such products may be counterfeit, contaminated, or improperly dosed, posing serious health risks. Always prioritize your safety by obtaining medications through legal and regulated channels.